Why ultrasound guidance matters for ChondroFiller hip injectionChondroFiller, an injectable collagen scaffold delivered via ultrasound-guided clinic injection, sets within the hip joint and draws the body's own progenitor cells to repair cartilage damage. Around 70–85% of patients report significant pain relief without surgery or general anaesthetic.ChondroFiller, an injectable collagen scaffold delivered via ultrasound-guided clinic injection, sets within the hip joint and draws the body's own progenitor cells to repair cartilage damage. Around 70–85% of patients report significant pain relief without surgery or general anaesthetic.
Choosing injection treatments for knee, hip and ankleHyaluronic acid injections can ease knee osteoarthritis pain for months, but the 2019 ACR/AF guideline recommends against routine use for knee disease and strongly against it for hip disease because average benefit is modest. Microfragmented fat and bone marrow concentrate are more experimental biologic options, with limited evidence and narrower…Hyaluronic acid injections can ease knee osteoarthritis pain for months, but the 2019 ACR/AF guideline recommends against routine use for knee disease and strongly against it for hip disease because average benefit is modest. Microfragmented fat and bone marrow concentrate are more experimental biologic options, with limited evidence and narrower uses in knee arthritis and talar cartilage lesions.
Choosing Arthrosamid knee injections for osteoarthritisArthrosamid is a single ultrasound-guided hydrogel injection for mild-to-moderate knee osteoarthritis, used when exercise, painkillers and other non-surgical care have not eased function-limiting pain. Early studies show meaningful improvement for many patients at 12 months, but evidence remains less robust than for established treatments.Arthrosamid is a single ultrasound-guided hydrogel injection for mild-to-moderate knee osteoarthritis, used when exercise, painkillers and other non-surgical care have not eased function-limiting pain. Early studies show meaningful improvement for many patients at 12 months, but evidence remains less robust than for established treatments.